William Hunter
Biochemistry
Sustainable Resource Engineering
Canada
Biography
Dr. William Hunter has been a member of Cardiome’s Board of Directors since 2007 and became the Company’s President and CEO in July, 2012. Prior to Cardiome, Dr. Hunter co-founded Angiotech Pharmaceuticals in 1992 and assumed the position of Chief Executive Officer in 1997 when Angiotech was a venture-stage, private, pre-clinical company with less than 50 employees. He led Angiotech through 3 rounds of private equity financing, the Company’s IPO and listing on the Toronto Stock Exchange and NASDAQ, over $1B in equity and debt financings, a debt restructuring and 8 separate corporate acquisitions. During that time, Angiotech grew to become a profitable, diversified, healthcare company with over 1,400 employees, several thousand commercially available products, 12 facilities in 5 countries and worldwide annual revenues exceeding $250M. Dr. Hunter currently serves a director of Epirus Biopharmaceuticals, Inc (NASDAQ: EPRS) and Union Medtech. Dr. Hunter served as a practicing physician in British Columbia for 5 years and has over 200 patents and patent applications to his name.
Research Interest
Biochemistry
